Form D — ADAPTIN BIO, INC.
0001578563-25-000148 · filed Feb 26, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $23,375,010
- Reported amount sold
- $13,077,849
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ADAPTIN BIO, INC.
- CIK
- 1938571
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 3540 TORINGDON WAY
CHARLOTTE, NC 28277 - Phone
- (888) 609-1498
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Roberts · Executive OfficerCharlotte, NC Find on LinkedIn ↗
-
Patrick Gallagher · DirectorCharlotte, NC Find on LinkedIn ↗
-
J. Nick Riehle · DirectorCharlotte, NC Find on LinkedIn ↗
-
Anthony Zook · DirectorCharlotte, NC Find on LinkedIn ↗
-
L. Arthur Hewitt · Executive OfficerCharlotte, NC Find on LinkedIn ↗
-
Timothy Maness · Executive OfficerCharlotte, NC Find on LinkedIn ↗
-
Simon Pedder · Executive OfficerCharlotte, NC Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗